Literature DB >> 9186590

Atherogenesis and advanced glycation: promotion, progression, and prevention.

A W Stitt1, R Bucala, H Vlassara.   

Abstract

Mesh：

Substances：

Year:  1997        PMID： 9186590     DOI： 10.1111/j.1749-6632.1997.tb51994.x

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN： 0077-8923            Impact factor:   5.691


× No keyword cloud information.
  17 in total

Review 1.  Advanced glycation: an important pathological event in diabetic and age related ocular disease.

Authors:  A W Stitt
Journal:  Br J Ophthalmol       Date:  2001-06       Impact factor: 4.638

Review 2.  Biology of corneal endothelial cells in vivo and in vitro.

Authors:  Shiro Amano; Yuichi Kaji; Tatsuya Mimura
Journal:  Jpn J Ophthalmol       Date:  2010-06-25       Impact factor: 2.447

3.  Genetic analysis of advanced glycation end products in the DHS MIND study.

Authors:  Jeremy N Adams; Laura M Raffield; Susan E Martelle; Barry I Freedman; Carl D Langefeld; J Jeffrey Carr; Amanda J Cox; Donald W Bowden
Journal:  Gene       Date:  2016-02-23       Impact factor: 3.688

4.  Dipeptidyl peptidase-4 deficiency protects against experimental diabetic nephropathy partly by blocking the advanced glycation end products-receptor axis.

Authors:  Takanori Matsui; Sae Nakashima; Yuri Nishino; Ayako Ojima; Nobutaka Nakamura; Kazunari Arima; Kei Fukami; Seiya Okuda; Sho-ichi Yamagishi
Journal:  Lab Invest       Date:  2015-03-02       Impact factor: 5.662

5.  Involvement of TAGE-RAGE System in the Pathogenesis of Diabetic Retinopathy.

Authors:  Masayoshi Takeuchi; Jun-Ichi Takino; Sho-Ichi Yamagishi
Journal:  J Ophthalmol       Date:  2010-06-22       Impact factor: 1.909

6.  Glycated LDL increases monocyte CC chemokine receptor 2 expression and monocyte chemoattractant protein-1-mediated chemotaxis.

Authors:  Kikuo Isoda; Eduardo Folco; M Reza Marwali; Fumitaka Ohsuzu; Peter Libby
Journal:  Atherosclerosis       Date:  2007-12-27       Impact factor: 5.162

Review 7.  Advanced glycation end products: role in pathology of diabetic cardiomyopathy.

Authors:  Vijaya Lakshmi Bodiga; Sasidhar Reddy Eda; Sreedhar Bodiga
Journal:  Heart Fail Rev       Date:  2014-01       Impact factor: 4.214

8.  DNA aptamer raised against advanced glycation end products inhibits melanoma growth in nude mice.

Authors:  Ayako Ojima; Takanori Matsui; Sayaka Maeda; Masayoshi Takeuchi; Hiroyoshi Inoue; Yuichiro Higashimoto; Sho-ichi Yamagishi
Journal:  Lab Invest       Date:  2014-02-10       Impact factor: 5.662

Review 9.  Advanced glycation End-products (AGEs): an emerging concern for processed food industries.

Authors:  Chetan Sharma; Amarjeet Kaur; S S Thind; Baljit Singh; Shiveta Raina
Journal:  J Food Sci Technol       Date:  2015-08-01       Impact factor: 2.701

10.  Combined therapy with metformin and insulin attenuates systemic and hepatic alterations in a model of high-fat diet-/streptozotocin-induced diabetes.

Authors:  Raquel Rangel Silvares; Evelyn Nunes Goulart da Silva Pereira; Edgar Eduardo Ilaquita Flores; Vanessa Estato; Patrícia Alves Reis; Igor José da Silva; Marcelo Pelajo Machado; Hugo Caire de Castro Faria Neto; Eduardo Tibiriça; Anissa Daliry
Journal:  Int J Exp Pathol       Date:  2016-07-06       Impact factor: 1.925
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.